Ambroxol-induced focal epileptic seizure
Authors: Lapenta L, Morano A, Fattouch J, Casciato S, Fanella M, Giallonardo AT, Di Bonaventura C
Date: 2014
Scope of interest: Epilepsy
06 99 39
Recup number
You may also be interested in:
Tocilizumab for patients with COVID-19pneumonia. The single-arm TOCIVID-19 prospective trial.
Authors: Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy.
Date: 2020
Scope of interest: sars cov 2 therapy
Read details
Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre.
Authors: Morano A, Fattouch J, Albini M, Casciato S, Fanella M, Basili LM, Viganò A, Manfredi M, Giallonardo AT, Di Bonaventura C.
Date: 2018
Scope of interest: Epilepsy
Read details
” Use of hyperimmune plasma for compassionate use in patients with Marginal Non-Hodgkin Lymphoma persistently positive for SARS CoV-2 infection”
Authors: C.D'Amico - F. De Angelis - F.Docimo – C.Gargiulo
Date: 2022
Scope of interest: CLINICAL PATHOLOGY
Read details
What to do to
Click on the icon of the service you are looking for and go to the dedicated section. If the service is not in the selection, go to Service Guide
